1. Urgent need for treatment addressing co-use of tobacco and cannabis: An updated review and considerations for future interventions
- Author
-
Nguyen, Nhung, Bold, Krysten W, and McClure, Erin A
- Subjects
Biological Psychology ,Clinical and Health Psychology ,Public Health ,Health Sciences ,Psychology ,Drug Abuse (NIDA only) ,Substance Misuse ,Behavioral and Social Science ,Cancer ,Mental Health ,Cannabinoid Research ,Tobacco Smoke and Health ,Tobacco ,Clinical Research ,Social Determinants of Health ,Prevention ,Clinical Trials and Supportive Activities ,Health Disparities ,Good Health and Well Being ,Humans ,Motivational Interviewing ,Cognitive Behavioral Therapy ,Tobacco Use Cessation Devices ,Marijuana Abuse ,Smoking cessation ,Tobacco use disorder ,Marijuana ,Cannabis use disorder ,Polysubstance use ,Treatment ,Review ,Public Health and Health Services ,Substance Abuse ,Public health ,Biological psychology ,Clinical and health psychology - Abstract
BackgroundThere are no clinical practice guidelines addressing the treatment of tobacco-cannabis co-use and a dearth of studies to inform treatment for co-use. This narrative review aims to (1) summarize promising intervention components used in published co-use treatment studies, (2) describe key gaps and emerging issues in co-use, and (3) provide recommendations and considerations in the development and evaluation of co-use interventions.MethodsWe conducted a literature search in June 2024 across several databases to update previous reviews on tobacco-cannabis co-use treatment. We found 9 published intervention studies that specifically addressed treatment for both substances. Data from these studies were manually extracted and summarized.ResultsMost of the 9 included studies (1) focused on acceptability and/or feasibility, (2) provided both psychosocial/behavioral and pharmacotherapy intervention components, (3) were conducted in adults, and (4) were delivered in-person, with some having digital asynchronous components, for a 5-to-12-week duration. The most common psychosocial/behavioral strategies used were Cognitive Behavioral Therapy, Motivational Interviewing, and Contingency Management; while the most common pharmacotherapy was Nicotine Replacement Therapy. There was no evidence of compensatory use of tobacco or cannabis when providing simultaneous treatment for both substances.ConclusionsThe literature to date provides support for well-integrated multi-component interventions of psychosocial/behavioral and pharmacotherapy strategies for co-use treatment. This review reinforces an urgent need for treatments targeting tobacco and cannabis co-use. Future interventions should address key gaps, including co-use of vaporized products among youth and young adults, tailored interventions for priority populations, and digital applications to increase reach and advance health equity.
- Published
- 2024